Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 663 of 1,261
  1. US 9499597

    Methods and compositions for treating Huntington's disease

    Sangamo Biosciences, Inc. · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  2. US 9499588

    Flaviviruses expressing the prM, E, and NS1 proteins of other flaviviruses and uses thereof

    The Board of Regents of the University of Texas System · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  3. US 9499568

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  4. US 9497945

    Humanized dipeptidyl peptidase IV (DPP4) animals

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  5. US 9498571

    Nitric oxide delivery devices

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  6. US 9499495

    Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways

    Asana BioSciences, LLC · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  7. US 9499494

    Pyrimidine-2,4,6-triones for use in the treatment of amyotrophic lateral sclerosis

    Northwestern University · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  8. US 9499516

    Nitrogen-containing heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  9. US 9499497

    Compounds useful as inhibitors of indoleamine 2,3-dioxygenase

    Vertex Pharmaceuticals Incorporated · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  10. US 9499493

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  11. US 9498544

    Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents

    Tissue Regeneration Therapeutics Inc. · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  12. US 9498529

    Methods for treating or preventing influenza virus infection by administering a serine protease inhibitor

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  13. US 9498566

    Selective cytopheresis devices and related methods thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  14. US 9498511

    Methods related to the treatment of neurodegenerative and inflammatory conditions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  15. US 9498537

    Method of enhancing efficacy of blood transfusions

    The Regents of the University of California · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  16. US 9499608

    Bispecific monoclonal antibody therapeutics against West Nile virus with improved CNS penetration

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  17. US 9498471

    Use of CDK9 inhibitors to reduce cartilage degradation

    The Regents of the University of California · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  18. US 9498445

    Pharmaceutical compositions for the treatment of Helicobacter pylori

    RedHill Biopharma Ltd. · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  19. US 9498526

    Human rotavirus vaccine strains and diagnostics

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  20. US 9499487

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  21. US 9499554

    Anti-influenza compositions and methods

    BioCryst Pharmaceuticals, Inc. · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  22. US 9502638

    Method of manufacturing flexible piezoelectric structures

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  23. US 9499818

    Methods and means for efficient skipping of at least one of the exons 51-53, 55, 57 and 59 of the human duchenne muscular dystrophy gene

    BIOMARIN TECHNOLOGIES B.V. · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  24. EP 3093014

    CABAZITAXEL UND DESSEN VERWENDUNG ZUR BEHANDLUNG VON KREBS

    AVENTIS PHARMA SA [FR] · Granted Nov 16, 2016 · Expires Nov 11, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.